NCT00778765View on ClinicalTrials.gov

Bioequivalence Study of Gabapentin 400 mg Capsules Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

October 31, 2002

Study Completion Date

December 31, 2002

Conditions
Healthy
Interventions
DRUG

400 mg Gabapentin Capsules

Trial Locations (1)

Unknown

MDS Pharma Services, Saint-Laurent

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00778765 - Bioequivalence Study of Gabapentin 400 mg Capsules Under Fed Conditions | Biotech Hunter | Biotech Hunter